Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Exercise × 90 days × Clear all

Sponsor

Conditions

Motor Activity 20 Breast Neoplasms 11 Neoplasms 6 Obesity 3 Lymphoma, Follicular 3 Lymphedema 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Sarcopenia 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Brain Neoplasms 2 Skin Neoplasms 1 Recurrence 1 Psychological Well-Being 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Myeloproliferative Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Essential Hypertension 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡